{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:00:35Z","timestamp":1777539635916,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.berh.2006.05.003","type":"journal-article","created":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T11:42:25Z","timestamp":1158752545000},"page":"791-807","source":"Crossref","is-referenced-by-count":38,"title":["Management of patients presenting with Sjogren's syndrome"],"prefix":"10.1016","volume":"20","author":[{"given":"P.J.","family":"Venables","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2006.05.003_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/berh.1999.0078","article-title":"Sjogren's syndrome: autoimmune epithelitis","volume":"14","author":"Manoussakis","year":"2000","journal-title":"Bailli\u00e8re's Best Practice & Research. Clinical Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2006.05.003_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American\u2013European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.003_bib4","unstructured":"Price EJ. Epithelial cell activation and Sjogren's syndrome. MD Thesis. Cardiff: University of Wales, 1997."},{"key":"10.1016\/j.berh.2006.05.003_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/rheumatology\/41.4.416","article-title":"Dry eyes and mouth syndrome \u2013 a subgroup of patients presenting with sicca symptoms","volume":"41","author":"Price","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2006.05.003_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/13543784.12.2.247","article-title":"Sjogren's syndrome: evolving therapies","volume":"12","author":"Fox","year":"2003","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.berh.2006.05.003_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/ard.60.11.1077","article-title":"Survey of artificial tear and saliva usage among patients with Sjogren's syndrome","volume":"60","author":"Mulherin","year":"2001","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.003_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/rheumatology\/33.3.278","article-title":"The treatment of sicca features in primary Sjogren's syndrome: a clinical review","volume":"33","author":"Foster","year":"1994","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/39.3.234","article-title":"Sjogren's syndrome \u2013 time for a new approach","volume":"39","author":"Dawson","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2006.05.003_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren's syndrome","volume":"159","author":"Vivino","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"supplement","key":"10.1016\/j.berh.2006.05.003_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/030097401300232583","article-title":"The treatment of Sjogren's syndrome with pilocarpine tablets","volume":"115","author":"Vivino","year":"2001","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","article-title":"A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca","volume":"46","author":"Petrone","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","article-title":"Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial","volume":"162","author":"Fife","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.berh.2006.05.003_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","article-title":"Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study","volume":"138","author":"Ono","year":"2004","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.berh.2006.05.003_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2169\/internalmedicine.38.938","article-title":"Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjogren's syndrome","volume":"38","author":"Miyawaki","year":"1999","journal-title":"Internal Medicine"},{"key":"10.1016\/j.berh.2006.05.003_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/096120339600500108","article-title":"Treatment of primary Sjogren's syndrome with hydroxychloroquine; a retrospective, open-label study","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2006.05.003_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/ard.52.5.360","article-title":"Hydroxychloroquine treatment for primary Sjogren's syndrome; a two year, double blind cross over trial","volume":"52","author":"Kruize","year":"1993","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.003_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.11199","article-title":"Treatment of primary Sjogren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results","volume":"49","author":"Cummins","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism","volume":"52","author":"Bave","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp.2004.049502","article-title":"Interferon alfa treatment for Sjogren's syndrome associated neuropathy","volume":"76","author":"Yamada","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.berh.2006.05.003_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02347624","article-title":"Development of Sjogren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C","volume":"31","author":"Unoki","year":"1996","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.berh.2006.05.003_bib22","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W","article-title":"Infliximab in patients with primary Sjogren's syndrome: a pilot study","volume":"44","author":"Steinfeld","year":"2001","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib23","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1002\/art.10674","article-title":"Infliximab in primary Sjogren's syndrome: one-year followup","volume":"46","author":"Steinfeld","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sjogren's syndrome: results of\u00a0the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib25","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.20299","article-title":"Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial","volume":"50","author":"Sankar","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib26","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2006.05.003_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1067\/moe.2002.121163","article-title":"Bilateral parotid swelling: a review","volume":"93","author":"Mandel","year":"2002","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics"},{"key":"10.1016\/j.berh.2006.05.003_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.md.0000121237.98962.1e","article-title":"Sarcoidosis or Sjogren syndrome? Clues to defining mimicry or coexistence in 59 cases","volume":"83","author":"Ramos-Casals","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2006.05.003_bib29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.14219\/jada.archive.2005.0345","article-title":"Treatment of refractory sarcoidal parotid gland swelling in a previously reported unresponsive case","volume":"136","author":"Mandel","year":"2005","journal-title":"Journal of the American Dental Association"},{"key":"10.1016\/j.berh.2006.05.003_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0889-857X(21)00323-9","article-title":"Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome","volume":"18","author":"Itescu","year":"1992","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"10.1016\/j.berh.2006.05.003_bib31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/rheumatology\/37.6.691","article-title":"Prevalence of Sjogren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology","volume":"37","author":"Kordossis","year":"1998","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(94)90630-0","article-title":"Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren's syndrome","volume":"344","author":"Terada","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2006.05.003_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00431-003-1277-9","article-title":"Primary Sjogren syndrome in the paediatric age: a multicentre survey","volume":"162","author":"Cimaz","year":"2003","journal-title":"European Journal of Pediatrics"},{"key":"10.1016\/j.berh.2006.05.003_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.58.4.253","article-title":"Hydroxychloroquine treatment for primary Sjogren's syndrome: its effect on salivary and serum inflammatory markers","volume":"58","author":"Tishler","year":"1999","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.003_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1079-2104(98)90158-5","article-title":"Sialographic changes in Sjogren's and SOX syndromes","volume":"86","author":"Drage","year":"1998","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"key":"10.1016\/j.berh.2006.05.003_bib36","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2006.05.003_bib37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/rheumatology\/37.10.1069","article-title":"Sjogren's syndrome: a community-based study of prevalence and impact","volume":"37","author":"Thomas","year":"1998","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib38","first-page":"474","article-title":"Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus","volume":"29","author":"Tench","year":"2002","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib39","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.286.11.1360","article-title":"Interventions for the treatment and management of chronic fatigue syndrome: a systematic review","volume":"286","author":"Whiting","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.berh.2006.05.003_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.003_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/ard.44.4.215","article-title":"Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects","volume":"44","author":"Moutsopoulos","year":"1985","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.003_bib42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/ard.59.9.709","article-title":"Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome","volume":"59","author":"Davidson","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2006.05.003_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00296-005-0010-6","article-title":"Polymyalgia rheumatica in primary Sjogren's syndrome","volume":"26","author":"Szodoray","year":"2005","journal-title":"Rheumatology International"},{"key":"10.1016\/j.berh.2006.05.003_bib44","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"The Quarterly Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.003_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9343(02)01380-3","article-title":"Sjogren's syndrome-associated myelopathy: response to immunosuppressive treatment","volume":"114","author":"Vincent","year":"2003","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.berh.2006.05.003_bib46","first-page":"962","article-title":"Sjogren's syndrome in patients with interstitial cystitis","volume":"20","author":"Van de Merwe","year":"1993","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib47","first-page":"185","article-title":"Clinical, serological and HLA phenotypes subsets in Sjogren's syndrome","volume":"17","author":"Pease","year":"1989","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2006.05.003_bib48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005792-200007000-00005","article-title":"Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome","volume":"79","author":"Goules","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2006.05.003_bib49","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","article-title":"Clinical and morphological features of kidney involvement in primary Sjogren's syndrome","volume":"16","author":"Bossini","year":"2001","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.berh.2006.05.003_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00296-005-0587-9","article-title":"A primary Sjogren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis. Report of a case study and review of the literature","volume":"26","author":"Soy","year":"2005","journal-title":"Rheumatology International"},{"key":"10.1016\/j.berh.2006.05.003_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0889-857X(05)70313-6","article-title":"Neonatal lupus syndromes","volume":"23","author":"Tseng","year":"1997","journal-title":"Rheumatic Diseases Clinics of North America"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694206000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694206000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T12:16:43Z","timestamp":1627820203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694206000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1521694206000519"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2006.05.003","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}